Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03987217 · ClinicalTrials.gov registry record · Early Phase 1
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
A Early Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 73
- Enrollment target
NCT03987217 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 73 participants.
The verdict
NCT03987217, a Early Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 73 participants
- Enrollment target
Study Summary
This trial studies how well resistance training with or without creatine monohydrate supplement works in improving body composition and health outcomes in patients with prostate cancer that has spread to other places in the body. Resistance training, with or without creatine monohydrate supplement, may help to improve feelings of tiredness and overall physical function in patients with prostate cancer.
Interventions
- OTHER Questionnaire Administration
- BEHAVIORAL Exercise Intervention
- DIETARY_SUPPLEMENT Creatine Monohydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2025-03-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03987217
The ClinicalTrials.gov registry entry for NCT03987217 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03987217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03987217 about?
NCT03987217 is a clinical study titled "Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients". This trial studies how well resistance training with or without creatine monohydrate supplement works in improving body composition and health outcomes in patients with prostate cancer that has spread to other places in the body. Resistance training, with or without creatine monohydrate supplement, ...
What is the current status of trial NCT03987217?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 73 participants. The study started on 2019-06-17. Estimated completion is 2025-03-10.
What interventions are being tested in trial NCT03987217?
The interventions under investigation include: Questionnaire Administration (OTHER), Exercise Intervention (BEHAVIORAL), Creatine Monohydrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03987217?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.